Mannkind (MNKD) Non Operating Income (2016 - 2026)
Mannkind's (MNKD) quarterly Non Operating Income came in at -$14.7 million in Q1 2026, down 69.42% year-on-year from -$48.1 million in Q1 2025, and down 10.99% on a QoQ basis from -$13.2 million in Q4 2025.
Mannkind (MNKD) Non Operating Income (2016 - 2026) Analysis & Trends
Mannkind (MNKD) has 11 years of Non Operating Income data on file, last reported at -$14.7 million in Q1 2026.
- On a quarterly basis, Non Operating Income fell 69.42% year-over-year to -$14.7 million in Q1 2026; TTM through Mar 2026 was -$43.4 million, a 3.34% increase from a year earlier, with the FY2025 full-year figure at -$37.4 million, up 11.11% from the prior year.
- Non Operating Income for Q1 2026 stood at -$14.7 million, down from -$13.2 million in the prior quarter.
- Over the last five years, Non Operating Income for MNKD reached as high as $110000.0 in Q3 2024 and fell as low as -$18.3 million in Q2 2024.
- Historically, Non Operating Income has averaged -$8.0 million across 5 years, with a median of -$5.8 million in 2024.
- Across the five-year window, Non Operating Income soared 103.26% in 2024 and plunged 10204.55% in 2025, its largest moves.
- Year by year, Non Operating Income stood at -$5.2 million in 2022, then gained by 5.06% to -$4.9 million in 2023, then sank by 268.67% to -$18.0 million in 2024, then gained by 26.63% to -$13.2 million in 2025, then declined by 10.99% to -$14.7 million in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were -$14.7 million in Q1 2026, -$13.2 million in Q4 2025, and -$11.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Mannkind | 1.20 Bn | 1.07 Bn | 82.66 Mn | -14.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.70 Mn |
| Dec 31, 2025 | -13.24 Mn |
| Sep 30, 2025 | -11.12 Mn |
| Jun 30, 2025 | -4.36 Mn |
| Mar 31, 2025 | -8.68 Mn |
| Dec 31, 2024 | -18.05 Mn |
| Sep 30, 2024 | 110,000.00 |
| Jun 30, 2024 | -18.30 Mn |
| Mar 31, 2024 | -5.83 Mn |
| Dec 31, 2023 | -4.90 Mn |
| Sep 30, 2023 | -3.38 Mn |
| Jun 30, 2023 | -6.99 Mn |
| Mar 31, 2023 | -3.80 Mn |
| Dec 31, 2022 | -5.16 Mn |
| Sep 30, 2022 | -4.82 Mn |
| Jun 30, 2022 | -8.57 Mn |
| Mar 31, 2022 | -4.74 Mn |
| Dec 31, 2021 | -4.09 Mn |
| Sep 30, 2021 | 2.16 Mn |
| Jun 30, 2021 | -25.25 Mn |